PAPER Jones DR, Moussaud S, McLean P
SEARCH RESULTS
331008 RESULTS
PAPER Ray A, Martinez BA, Berkowitz LA, Caldwell GA, Caldwell KA
Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model.
Cell Death Dis. 2014 Jan 9;5:e984. PubMed: 24407237PAPER Suzuki Y, Jin C, Yazawa I
Cystatin C triggers neuronal degeneration in a model of multiple system atrophy.
Am J Pathol. 2014 Mar;184(3):790-9. Epub 2014 Jan 7 PubMed: 24405769PAPER Gerber YN, Privat A, Perrin FE
Gacyclidine improves the survival and reduces motor deficits in a mouse model of amyotrophic lateral sclerosis.
Front Cell Neurosci. 2013 Dec 27;7:280. PubMed: 24409117PAPER Sarica A, Cerasa A, Vasta R, Perrotta P, Valentino P, Mangone G, Guzzi PH, Rocca F, Nonnis M, Cannataro M, Quattrone A
Tractography in amyotrophic lateral sclerosis using a novel probabilistic tool: a study with tract-based reconstruction compared to voxel-based approach.
J Neurosci Methods. 2014 Mar 15;224:79-87. Epub 2014 Jan 6 PubMed: 24406465PAPER Estevez AO, Morgan KL, Szewczyk NJ, Gems D, Estevez M
The neurodegenerative effects of selenium are inhibited by FOXO and PINK1/PTEN regulation of insulin/insulin-like growth factor signaling in Caenorhabditis elegans.
Neurotoxicology. 2014 Mar;41:28-43. Epub 2014 Jan 6 PubMed: 24406377PAPER Mosconi L
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.
Clin Transl Imaging. 2013 Aug;1(4) PubMed: 24409422PAPER Meng J, Li Y, Camarillo C, Yao Y, Zhang Y, Xu C, Jiang L
The anti-tumor histone deacetylase inhibitor SAHA and the natural flavonoid curcumin exhibit synergistic neuroprotection against amyloid-beta toxicity.
PLoS One. 2014;9(1):e85570. Epub 2014 Jan 7 PubMed: 24409332PAPER Rathakrishnan BG, Doraiswamy PM, Petrella JR
Science to practice: translating automated brain MRI volumetry in Alzheimer's disease from research to routine diagnostic use in the work-up of dementia.
Front Neurol. 2014 Jan 9;4:216. PubMed: 24409168PAPER Garcés P, Vicente R, Wibral M, Pineda-Pardo JÁ, López ME, Aurtenetxe S, Marcos A, de Andrés ME, Yus M, Sancho M, Maestú F, Fernández A
Brain-wide slowing of spontaneous alpha rhythms in mild cognitive impairment.
Front Aging Neurosci. 2013 Dec 27;5:100. PubMed: 24409145PAPER Caillet-Boudin ML, Fernandez-Gomez FJ, Tran H, Dhaenens CM, Buee L, Sergeant N
Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.
Front Mol Neurosci. 2014 Jan 9;6:57. PubMed: 24409116PAPER Gardette V, Lapeyre-Mestre M, Piau A, Gallini A, Cantet C, Montastruc JL, Vellas B, Andrieu S, ICTUS Group
A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe: predictors of discontinuation and switch in the ICTUS study.
CNS Drugs. 2014 Feb;28(2):157-70. PubMed: 24408842PAPER Azizi G, Khannazer N, Mirshafiey A
The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.
Am J Alzheimers Dis Other Demen. 2014 Jan 8; PubMed: 24408754PAPER Olazarán J, Ramos A, Boyano I, Alfayate E, Valentí M, Rábano A, Alvarez-Linera J
Pattern of and risk factors for brain microbleeds in neurodegenerative dementia.
Am J Alzheimers Dis Other Demen. 2014 May;29(3):263-9. Epub 2014 Jan 8 PubMed: 24408753PAPER Jedrziewski MK, Ewbank DC, Wang H, Trojanowski JQ
The Impact of Exercise, Cognitive Activities, and Socialization on Cognitive Function: Results From the National Long-Term Care Survey.
Am J Alzheimers Dis Other Demen. 2014 Jan 8;29(4):372-378. PubMed: 24408752Current Filters
No filters selected